Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasms, Kidney”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06909968
What this trial is testing

Identification of Palliative Care Needs and Prognostic Factors of Survival in Tailoring Appropriate Interventions in Advanced Oncological, Renal and Pulmonary Diseases

Who this might be right for
CancerChronic Renal FailureChronic Obstructive Pulmonary Disease+1 more
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 178
Not applicableActive Not RecruitingNCT05871008
What this trial is testing

Integrated Actionable Aging Assessment for Cancer Patients Pilot

Who this might be right for
Breast CancerHodgkin LymphomaKidney Cancer+7 more
University of Colorado, Denver 35
Early research (Phase 1)Study completedNCT03200587
What this trial is testing

Cabometyx and Avelumab in Patients With Metastatic Renal Cell Carcinoma (mRCC)

Who this might be right for
Renal Cell Carcinoma
University of Utah 12
Testing effectiveness (Phase 2)Study completedNCT00035243
What this trial is testing

EPO906 Therapy in Patients With Advanced Kidney Cancer

Who this might be right for
Kidney Neoplasms
Novartis Pharmaceuticals 53
Not applicableLooking for participantsNCT07753343
What this trial is testing

Identification and Description of Patients With High-risk Non Metastatic RCC

Who this might be right for
Renal Cell Carcinoma
University Hospital, Bordeaux 6,109
Testing effectiveness (Phase 2)Study completedNCT03494816
What this trial is testing

Study of Axitinib for Reducing Extent of Venous Tumour Thrombus in Renal Cancer With Venous Invasion

Who this might be right for
Renal Cell CarcinomaMetastatic Renal Cell CarcinomaNon-metastatic Renal Cell Carcinoma
Scottish Clinical Trials Research Unit 24
Not applicableUnknownNCT02858778
What this trial is testing

Timing of Acute Palliative Care Consultation in Critically Ill Patients

Who this might be right for
Multiple Organ FailureEnd Stage Cardiac FailureEnd Stage Chronic Obstructive Airways Disease+8 more
Wayne State University 120
Early research (Phase 1)Study completedNCT01569815
What this trial is testing

Pharmacokinetics of LCZ696 in Subjects With Mild and Moderate Renal Impairment Compared to Healthy Subjects With Normal Renal Function

Who this might be right for
Mild and Moderate Renal Impairment
Novartis Pharmaceuticals 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT02721732
What this trial is testing

Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic

Who this might be right for
Advanced Malignant Solid NeoplasmCarcinoma of Unknown PrimaryMetastatic Adrenal Gland Pheochromocytoma+16 more
M.D. Anderson Cancer Center 157
Early research (Phase 1)Study completedNCT00045006
What this trial is testing

Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT01431326
What this trial is testing

Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care

Who this might be right for
AdenovirusAnesthesiaAnxiety+56 more
Daniel Benjamin 3,520
Not applicableStudy completedNCT03744585
What this trial is testing

Cabozantinib Real-life Use for Advanced Renal Cell Carcinoma in France: a Retrospective Descriptive Non-interventional Study of 2 Cohorts.

Who this might be right for
Renal Cell Carcinoma
Ipsen 450
Testing effectiveness (Phase 2)Looking for participantsNCT07227415
What this trial is testing

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

Who this might be right for
Carcinoma, Renal CellAdvanced Renal Cell CarcinomaRenal Cancer+10 more
Pfizer 224
Testing effectiveness (Phase 2)Study completedNCT05963334
What this trial is testing

Comparison of Weekly Versus Every Three Weeks of Carboplatin Plus Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer

Who this might be right for
Advanced Epithelial Ovarian Cancer
Cairo University 49
Not applicableLooking for participantsNCT03702309
What this trial is testing

Liquid Biopsy Evaluation and Repository Development at Princess Margaret

Who this might be right for
CancerBreast CancerLung Cancer+15 more
University Health Network, Toronto 2,500
Testing effectiveness (Phase 2)Ended earlyNCT01762033
What this trial is testing

ASONEP™ to Treat Unresectable and Refractory Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Lpath, Inc. 40
Post-approval studies (Phase 4)Active Not RecruitingNCT05252585
What this trial is testing

A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML)

Who this might be right for
Renal Angiomyolipoma
Novartis Pharmaceuticals 4
Early research (Phase 1)Looking for participantsNCT07564232
What this trial is testing

Phase 1 Study Of LNK001 In Advanced Or Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Ended earlyNCT03652298
What this trial is testing

Effects of a Neuroscience-based Technique on Cancer Patients Announced of a Palliative Disease Progression and Partners

Who this might be right for
Colorectal CancerBladder CancerProstate Cancer+2 more
Centre Oscar Lambret 19
Not applicableWithdrawnNCT02108587
What this trial is testing

Optical Coherence Tomography in Staging Patients With Upper Tract Urothelial Cancer

Who this might be right for
Kidney/Urinary Cancer
Case Comprehensive Cancer Center
Next Page